DrugCite
Search

DEXAMETHASONE ACETATE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Dexamethasone Acetate Adverse Events Reported to the FDA Over Time

How are Dexamethasone Acetate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Dexamethasone Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Dexamethasone Acetate is flagged as the suspect drug causing the adverse event.

Most Common Dexamethasone Acetate Adverse Events Reported to the FDA

What are the most common Dexamethasone Acetate adverse events reported to the FDA?

Pneumonia
1144 (1.49%)
Pyrexia
1024 (1.33%)
Neutropenia
984 (1.28%)
Diarrhoea
904 (1.18%)
Thrombocytopenia
865 (1.13%)
Sepsis
760 (.99%)
Dyspnoea
694 (.9%)
Fatigue
694 (.9%)
Anaemia
684 (.89%)
Febrile Neutropenia
678 (.88%)
Platelet Count Decreased
605 (.79%)
Show More Show More
Death
603 (.79%)
Nausea
603 (.79%)
Haemoglobin Decreased
592 (.77%)
Vomiting
586 (.76%)
Hypotension
579 (.75%)
Dehydration
548 (.71%)
Asthenia
541 (.7%)
Disease Progression
519 (.68%)
Multiple Myeloma
494 (.64%)
Renal Failure Acute
493 (.64%)
Infection
487 (.63%)
Deep Vein Thrombosis
474 (.62%)
Pancytopenia
466 (.61%)
Renal Failure
454 (.59%)
Pulmonary Embolism
445 (.58%)
Constipation
440 (.57%)
Neuropathy Peripheral
435 (.57%)
General Physical Health Deteriorati...
425 (.55%)
Confusional State
392 (.51%)
Atrial Fibrillation
388 (.51%)
Hyperglycaemia
388 (.51%)
Abdominal Pain
386 (.5%)
White Blood Cell Count Decreased
373 (.49%)
Pleural Effusion
360 (.47%)
Septic Shock
360 (.47%)
Respiratory Failure
357 (.47%)
Pain
304 (.4%)
Hyponatraemia
300 (.39%)
Rash
298 (.39%)
Dizziness
295 (.38%)
Chest Pain
290 (.38%)
Multi-organ Failure
282 (.37%)
Oedema Peripheral
275 (.36%)
Headache
271 (.35%)
Blood Creatinine Increased
269 (.35%)
Back Pain
268 (.35%)
Leukopenia
257 (.33%)
Hypokalaemia
255 (.33%)
Drug Ineffective
251 (.33%)
Neutrophil Count Decreased
242 (.32%)
Cough
230 (.3%)
Convulsion
228 (.3%)
Haemorrhage
228 (.3%)
Hypoxia
228 (.3%)
Alanine Aminotransferase Increased
226 (.29%)
Malaise
222 (.29%)
Condition Aggravated
221 (.29%)
Tachycardia
221 (.29%)
Hypertension
216 (.28%)
Mucosal Inflammation
214 (.28%)
Decreased Appetite
213 (.28%)
Fall
204 (.27%)
Muscular Weakness
204 (.27%)
Somnolence
202 (.26%)
Drug Interaction
201 (.26%)
Osteonecrosis
201 (.26%)
Cardiac Failure
199 (.26%)
Gastrointestinal Haemorrhage
196 (.26%)
Syncope
194 (.25%)
Aspartate Aminotransferase Increase...
193 (.25%)
Tumour Lysis Syndrome
192 (.25%)
Malignant Neoplasm Progression
191 (.25%)
Pain In Extremity
188 (.24%)
Lung Disorder
185 (.24%)
Arthralgia
183 (.24%)
Chills
181 (.24%)
Herpes Zoster
181 (.24%)
Blood Glucose Increased
180 (.23%)
Staphylococcal Infection
179 (.23%)
Myelodysplastic Syndrome
177 (.23%)
Cardiac Arrest
175 (.23%)
Hypocalcaemia
175 (.23%)
Thrombosis
174 (.23%)
Urinary Tract Infection
174 (.23%)
Drug Toxicity
171 (.22%)
Insomnia
171 (.22%)
Weight Decreased
171 (.22%)
Haematocrit Decreased
167 (.22%)
Cellulitis
164 (.21%)
C-reactive Protein Increased
163 (.21%)
Hypoaesthesia
155 (.2%)
Renal Impairment
150 (.2%)
Pulmonary Oedema
149 (.19%)
Mental Status Changes
147 (.19%)
Acute Respiratory Distress Syndrome
146 (.19%)
Blood Lactate Dehydrogenase Increas...
146 (.19%)
Atelectasis
145 (.19%)
Colitis
144 (.19%)
Agitation
142 (.18%)
International Normalised Ratio Incr...
142 (.18%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Dexamethasone Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Dexamethasone Acetate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Dexamethasone Acetate

What are the most common Dexamethasone Acetate adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Dexamethasone Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Dexamethasone Acetate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Dexamethasone Acetate According to Those Reporting Adverse Events

Why are people taking Dexamethasone Acetate, according to those reporting adverse events to the FDA?

Multiple Myeloma
9669
Drug Use For Unknown Indication
1833
Premedication
1761
Prophylaxis
1409
Product Used For Unknown Indication
1118
Acute Lymphocytic Leukaemia
780
Show More Show More
Prophylaxis Of Nausea And Vomiting
542
Nausea
384
Mantle Cell Lymphoma
333
Antiemetic Supportive Care
296
Non-hodgkins Lymphoma
255
Amyloidosis
226
Chemotherapy
203
Chronic Lymphocytic Leukaemia
178
Lymphoma
168
Vomiting
144
B-cell Lymphoma
140
Prostate Cancer
135
Brain Oedema
124
Pain
117
Metastases To Central Nervous Syste...
117
Diffuse Large B-cell Lymphoma
115
Supplementation Therapy
106
Plasmacytoma
97
Myeloma Recurrence
81
Burkitts Lymphoma
77
Breast Cancer
66
Diffuse Large B-cell Lymphoma Recur...
65
Glioblastoma Multiforme
59
Leukaemia Plasmacytic
54
B Precursor Type Acute Leukaemia
54
Histiocytosis Haematophagic
53
Inflammation
48
Antiinflammatory Therapy
47
Rheumatoid Arthritis
46
Waldenstroms Macroglobulinaemia
45
Oedema
44
Prostate Cancer Stage Iv
44
Primary Amyloidosis
43
Acute Myeloid Leukaemia
43
T-cell Lymphoma Stage Iv
42
Fatigue
42
Prophylactic Chemotherapy
41
Ill-defined Disorder
39
Dyspnoea
39
Asthma
38
T-cell Lymphoma
37
Peripheral T-cell Lymphoma Unspecif...
37
Glioblastoma
37
T-cell Type Acute Leukaemia
36
Hodgkins Disease
34

Dexamethasone Acetate Case Reports

What Dexamethasone Acetate safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Dexamethasone Acetate. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Dexamethasone Acetate.